Disposable Syringes Market To Reach USD 9.9 Billion By 2024: Grand View Research, Inc.
The global disposable syringes
market is expected to reach a value of USD 9.9 billion by 2024,
according to a new report by Grand View Research, Inc. The market growth can be
attributed to the rising initiatives by government and various NGOs to raise
awareness about safe drug delivery to patients in order to avoid transmission
of infections and avoid needle stick injuries to healthcare workers, especially
in low-income countries.
Organizations such as WHO and UNAIDS are constantly working
for this cause. Some of their programs include needle and syringe program and
targeted information for drug abusers. The results of these initiatives are
evident. For instance, in China, the incidence of HIV/AIDS amongst people who
are drug abusers dropped from 2.5 to 0.6 cases per 100 person-years.
Major disposable syringe manufacturers are introducing new
products, which is also further augmenting the market growth. In January 2016,
Novo Nordisk launched Tresiba, a long-acting insulin degludec injection to
treat diabetes. It was initially launched in U.S. and will further target the
rest of the market.
Some of the key industry players are Braun Medical, Inc.;
Fresenius Kabi AG; Baxter International, Inc.; Terumo Corporation; Novo
Nordisk; Covidien; Retractable Technologies, Inc.; and Becton, Dickinson, and
Company.
Browse full research report on Disposable Syringes Market: http://www.grandviewresearch.com/industry-analysis/disposable-syringes-market
Further Key Findings from the Study Suggest:
- Safety
syringes dominated the product segment in 2015 as they provide long-term
cost advantage in comparison to the traditional syringes and thus are
preferred by healthcare professionals.
- Therapeutic
injections dominated the application segment in 2015 due to the extensive
use of injectable drugs in treatment of high prevalence diseases such as
HIV, Hepatitis B & C, and diabetes coupled with increasing rate of
volunteer blood donations are few reasons for high demand of infusion
devices across the globe.
- Africa
does not have established production systems, thus is considered a high
potential market.
- In
2015, North America dominated due to approval of injectable drugs. For
instance, in July 2015, the U.S. FDA approved Praluent (alirocumab) which
is the first injectable from PCSK9) inhibitors class.
- The
industry has witnessed few major acquisitions. In 2015, Covidien was
acquired by Medtronic, Inc in USD 42.9 billion. Moreover, new product
development is also on a rise in the industry.
Grand View Research has segmented the disposable syringes
market by type, application and region:
Global Type Outlook (Market revenue in USD Million, 2013
- 2024)
- Conventional
syringes
- Safety
syringes
- Retractable
safety syringes
- Non-retractable
safety syringes
Global Application Outlook (Market revenue in USD
Million, 2013 - 2024)
- Immunization
injections
- Therapeutic
injections
Regional Outlook (Market Revenue in USD Million,
2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-disposable-syringes-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment